Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Vitamin D Supplement in patients with CKD stage 1 and 2 may change osteoprotegin expression so as to produce beneficial effects of cardiovascular、bone metabolism and CKD progression.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taixing People's Hospital
• Treatments: Calcitriol

Criteria

Inclusion Criteria:

• Clinical diagnosis of CKD stage 1 and 2

• Age >18 years

• Ability to provide informed consent

Exclusion Criteria:

• On vitamin D in past 4 weeks

• Plans to relocate out of Taixing City in the next one year

• Serum phosphate >5.5 mg/dl in past 3 months

• Serum calcium >10.0 mg/dl in past 3 months

• Cancer

• Transplanted organ

• Rapidly deteriorating kidney function with the expectation for initiation of dialysis in less than 6 months